首页> 外文期刊>Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology >Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection.
【24h】

Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection.

机译:一氧化氮合酶抑制剂氨基胍可减少Theiler病毒感染引起的炎症和脱髓鞘。

获取原文
获取原文并翻译 | 示例
           

摘要

This study evaluated effects of the inducible nitric oxide synthase (iNOS) inhibitor, aminoguanidine (AG), on the neuropathology and clinical disease produced by Theiler's murine encephalomyelitis virus (TMEV) DA strain infection. Treatment with AG was started on day 7, 14, 28 or 66 post-inoculation and continued for a minimum of 21 days. Inflammation, demyelination and axonal necrosis were scored in a blinded fashion on spinal cord sections from each mouse. Reduction in inflammation, demyelination and axonal necrosis was observed in mice treated with AG. Apoptosis within the spinal cord parenchyma and perivascular cuffs was significantly decreased. AG treatment resulted in delayed onset of clinical disease.
机译:这项研究评估了诱导型一氧化氮合酶(iNOS)抑制剂氨基胍(AG)对Theiler鼠脑脊髓炎病毒(TMEV)DA株感染产生的神经病理学和临床疾病的影响。在接种后第7、14、28或66天开始用AG治疗,并持续至少21天。在每只小鼠的脊髓切片上以盲法对炎症,脱髓鞘和轴突坏死进行评分。在用AG处理的小鼠中观察到炎症,脱髓鞘和轴突坏死的减少。脊髓实质和血管周袖内的细胞凋亡明显减少。 AG治疗导致临床疾病的延迟发作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号